僅用于工業(yè)應(yīng)用或科學(xué)研究，不可用于人類或動(dòng)物的臨床診斷或治療，非藥用. Conatumumab （AMG 655） is a human monoclonal agonist antibody against human death receptor 5 （DR5, TRAILR2） （Kd: 1 nM for the long form of DR5, 0.8 nM for the short form of DR5）. Conatumumab induces apoptosis via caspase activation. Conatumumab can be used in the research of cancers